Prohibits the possession and sale of certain mitragynine-derived products

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 6 Sponsors

Mar 11, 2026 · House

Executive Session Continued

Mar 11, 2026 · House

Action Postponed (H)

Feb 25, 2026 · House

Public Hearing Completed (H)

Feb 9, 2026 · House

Referred: Emerging Issues(H)

Feb 4, 2026 · House

Read Second Time (H)

Feb 3, 2026 · House

Introduced and Read First Time (H)

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Floor Consideration — base rate 2%, measured from MO's completed sessions
Momentum -2 43/100 from the pace of recorded action
Time since last action -22 215 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.